Navigation Links
TB Patient Pleads President for Mercy Killing

Unable to cope with his suffering, a tuberculosis (TB) patient in Madhya Pradesh has requested Indian President A.P.J. Abdul Kalam to allow him //to end his own life and that of his four minor children.

Uttam Singh Ojha, a resident of Guna who is in his late 40s, is suffering from TB and has long been dependent on his children for moving around. His wife too had died of TB a few years ago.

He has now written to Kalam seeking permission to kill himself and his four sons, reports said.

Ojha had sought help from Chief Minister Shivraj Singh Chouhan and Guna MP Jyotiraditya Scindia but did not receive any response from either.

His eldest son is just 14 years old and all the four sons had been working in hotels to make ends meet. But now all of them have stopped going out for work as Ojha's condition has worsened and he cannot be left alone. As a result, the family is on the brink of starvation.

Top Guna administrative official G.K. Saraswat said he was not aware of Ojha's plight but told IANS on telephone: "We will definitely look into the matter if a request comes from the family."

(Source: IANS News)
'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patient’s perception of health status helps in better recover
7. Patients often assume wrongly that they are allergic to penicillin
8. New FDA Approved Drug NATRECOR For Heart Failure Patients
9. Hemochromatosis Patients Blood is Safe
10. Fifth US Patient Receives Artificial Heart
11. Patients Pressure Would Result In Overprescription
Post Your Comments:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...moking is associated with an increased risk of dis... A new study has highlighted that smoker’s childre... a bacteria that can cause pneumonia, sinusitis an...e in the cigarette price, ban on smoking seems to ...
...dental health a common concern is fluoride which i... teeth.// This is a revelation of several studies ...ntal Research's annual meeting from March 8, 2006,...da. Some important findings and studies are as men...
... prescribed by the physicians to those in the cate...normal heart rhythm. They are less commonly given ...m are the highest. In case of elders also those wh...llation, are not prescribed warfarin when they are...
Health Industry On An Upward Swing In Germany
Other Medicine News:Health News:Warfarin the Not So Popular Drug for Stroke 2
(Date:9/4/2008)...ctice Bulletin for Obstetrician-Gynecologists Stat...e Change-Minimally Invasive Interventional,Radiolo...ith Uterine,Fibroids, FAIRFAX, Va., Sept. 4 /PRNe...l Radiology, a national organization of nearly 4,5...nals dedicated to improving health,care through mi...
(Date:9/4/2008)... Updated Survival Data for Ipilimumab to be Pr...stCall/ -- Medarex, Inc.,(Nasdaq: MEDX ) announce...b,an investigational anti-CTLA-4 antibody, in mel...ions at the 33rd Congress of the European Society,...2-16, 2008 in Stockholm.,Many of the following abs...
(Date:9/3/2008)...NEY, Australia, Sept. 4 /Xinhua-PRNewswire-FirstCa... Nasdaq: PXSL) today announced,that it has enrolle...3,clinical trial evaluating Bronchitol in cystic f...nducted in 41 hospitals across North,America, Arge...before,Pharmaxis seeks approval to market Bronchit...
(Date:9/3/2008)...ong term follow up results from chronically infect...d positive data obtained earlier in 2008, - Stud... and long-term antiviral effect of therapeu... and strongly support move into a second generatio...C31(R) acting through TLR ...
Breaking Medicine Technology:Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Research suggests parts of UK could be too hot for wine making by 2080 3441 1Research suggests parts of UK could be too hot for wine making by 2080 3441 2New unifying theory of lasers advanced by physicists 5648 1New unifying theory of lasers advanced by physicists 5648 2GenoLogics Releases BioVault Biospecimen Management Software in Partnership With GenVault Corporation 20346 1GenoLogics Releases BioVault Biospecimen Management Software in Partnership With GenVault Corporation 20346 2GenoLogics Releases BioVault Biospecimen Management Software in Partnership With GenVault Corporation 20346 3WuXi PharmaTech Announces First Quarter 2008 Results 5647 1WuXi PharmaTech Announces First Quarter 2008 Results 5647 2WuXi PharmaTech Announces First Quarter 2008 Results 5647 3WuXi PharmaTech Announces First Quarter 2008 Results 5647 4WuXi PharmaTech Announces First Quarter 2008 Results 5647 5WuXi PharmaTech Announces First Quarter 2008 Results 5647 6WuXi PharmaTech Announces First Quarter 2008 Results 5647 7WuXi PharmaTech Announces First Quarter 2008 Results 5647 8WuXi PharmaTech Announces First Quarter 2008 Results 5647 9WuXi PharmaTech Announces First Quarter 2008 Results 5647 10WuXi PharmaTech Announces First Quarter 2008 Results 5647 11
...NESS WIRE)--Mar 26, 2007 - CombinatoRx,Incorporat...lts of,a phase 2 clinical trial studying CRx-139 (...the antidepressant paroxetine),and 3mg prednisolon...). This trial served two important purposes. One p...isolone alone (a very low dose),in RA and to contr...
...l Center Only Illinois Site in Trial , CHICAGO, Ma...n,new intravenous adult stem cell therapy, Provace...ents, such as cardiac,arrhythmias, and had signifi...on compared to those who received a placebo, accor...the American College,of Cardiology’s Innovat...
Other Medicine Technology:CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 2CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 3CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 4CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 5CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 6Heart Attack Patients Treated With Novel Stem Cell Therapy,Experience Significant Improvement in Heart and Lung Function 2Heart Attack Patients Treated With Novel Stem Cell Therapy,Experience Significant Improvement in Heart and Lung Function 3
The MD Coder is simply more than a reference guide: it is a handheld solution for accurate coding and patient tracking for both individual physicians and small practice groups. MD Coder v6.0 now come
Integrated patient tracking and billing. This product contains the complete Handheld application, a complete Desktop application, and complete CPT™ and ICD-9-CM codes licensed from the AMA. Desi
PharmD ToolBox is an advanced medical calculator and rapid reference for Emergency, Pediatric Dosing and Critical Care for PharmDs. This product is a logical complement to other PDA reference product
iFacts™ is the handheld version of Drug Interaction Facts, a drug interaction analyzer covering thousands of brand and generic drugs. iFacts™ enables the practitioner to refer to accurate a
Medicine Products: